
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于本次非公开发行股票不存在直接或通过利益相关方向参与认购的投资者提供财务资助或补偿的公告 | 2022-08-17 | Chinese | |
| 天域生态 非公开发行股票预案 | 2022-08-17 | Chinese | |
| 最近五年未被证券监管部门和交易所采取监管措施或处罚的公告 | 2022-08-17 | Chinese | |
| 关于非公开发行股票摊薄即期回报及采取填补措施和相关主体承诺的公告 | 2022-08-17 | Chinese | |
| 关于公司2022年半年度募集资金存放与实际使用情况的专项报告 | 2022-08-11 | Chinese | |
| 2022年半年度报告 | 2022-08-11 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 38181405 | 关于本次非公开发行股票不存在直接或通过利益相关方向参与认购的投资者提供财务资助或补偿的公告 | 2022-08-17 | Chinese | ||
| 38181391 | 天域生态 非公开发行股票预案 | 2022-08-17 | Chinese | ||
| 38181368 | 最近五年未被证券监管部门和交易所采取监管措施或处罚的公告 | 2022-08-17 | Chinese | ||
| 38181348 | 关于非公开发行股票摊薄即期回报及采取填补措施和相关主体承诺的公告 | 2022-08-17 | Chinese | ||
| 38181330 | 关于公司2022年半年度募集资金存放与实际使用情况的专项报告 | 2022-08-11 | Chinese | ||
| 38181314 | 2022年半年度报告 | 2022-08-11 | Chinese | ||
| 38181268 | 天域生态信息披露暂缓与豁免内部管理制度(2022年08月修订) | 2022-08-11 | Chinese | ||
| 38181216 | 天域生态对外投资管理制度(2022年08月修订) | 2022-08-11 | Chinese | ||
| 38181205 | 第三届监事会第二十六次会议决议公告 | 2022-08-11 | Chinese | ||
| 38181193 | 天域生态内幕信息知情人登记及保密制度(2022年08月修订) | 2022-08-11 | Chinese | ||
| 38181175 | 董事会审计委员会工作细则(2022年08月修订) | 2022-08-11 | Chinese | ||
| 38181164 | 2022年半年度报告摘要 | 2022-08-11 | Chinese | ||
| 38181138 | 第三届董事会第四十五次会议决议公告 | 2022-08-11 | Chinese | ||
| 38181126 | 天域生态投资者关系管理制度(2022年08月修订) | 2022-08-11 | Chinese | ||
| 38181113 | 关于修订部分制度的公告 | 2022-08-11 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.